NASDAQ · Price History

Avalyn Pharma Inc. (AVLN) Stock Price History & Returns

$27.92 NASDAQ: AVLN Market Cap $1.24B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Avalyn Pharma Inc. (AVLN) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $27.92 sits 32% of the way up a 52-week range of $22.24 to $40.17; 30.5% below the 52-week high; below its 50-day moving average of $28.87; below its 200-day average of $29.91; a beta of -1.13 means it has historically moved opposite the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-22.9%
6 months+1.5%

Monthly closing prices

The last 8 months, newest first. 3 of 7 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$27.92+8.9%
October 2026$25.63-10.0%
September 2026$28.49-18.0%
August 2026$34.73+20.6%
July 2026$28.79-12.5%
June 2026$32.92+14.4%
May 2026$28.78-2.4%
April 2026$29.49—

Avalyn Pharma Inc. (AVLN) price history — frequently asked questions

How has Avalyn Pharma Inc. performed over the last year?

Avalyn Pharma Inc. (AVLN) has risen 0.0% over the last twelve months, measured on price alone.

What is Avalyn Pharma Inc.'s five-year return?

Over five years the AVLN share price has gained 0.0%, excluding dividends.

What is Avalyn Pharma Inc.'s 52-week range?

Over the last year Avalyn Pharma Inc. (AVLN) has traded between $22.24 and $40.17.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.